Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal
Mohammad Sultan Khuroo
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 3, pp. 106101-106101
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19
Joydeb Majumder, Tamara Minko
The AAPS Journal (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 430
COVID-19 vaccines: rapid development, implications, challenges and future prospects
Shivaji Kashte, Arvind Gulbake, Saadiq F. El‐Amin, et al.
Human Cell (2021) Vol. 34, Iss. 3, pp. 711-733
Open Access | Times Cited: 355
COVID-19 Epidemic in Malaysia: Epidemic Progression, Challenges, and Response
Jamal Hisham Hashim, Mohammad Adam Adman, Zailina Hashim, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 185
Machine and Deep Learning towards COVID-19 Diagnosis and Treatment: Survey, Challenges, and Future Directions
Tarik Alafif, Abdul Muneeim Tehame, Saleh Bajaba, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 3, pp. 1117-1117
Open Access | Times Cited: 125
Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges
Vineela Parvathaneni, Vivek Gupta
Life Sciences (2020) Vol. 259, pp. 118275-118275
Open Access | Times Cited: 121
COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation!
Mohammad Sultan Khuroo, Mohammad Sultan Khuroo, Mehnaaz S. Khuroo, et al.
Journal of Clinical and Experimental Hepatology (2020) Vol. 10, Iss. 6, pp. 610-621
Open Access | Times Cited: 93
Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking
Pooyan Makvandi, Meiling Chen, Rossella Sartorius, et al.
Nano Today (2021) Vol. 40, pp. 101279-101279
Open Access | Times Cited: 93
Nanocarrier vaccines for SARS-CoV-2
Jatin Machhi, Farah Shahjin, Srijanee Das, et al.
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 215-239
Open Access | Times Cited: 90
One Year of Coronavirus Disease 2019 (COVID-19) in Brazil: A Political and Social Overview
Matheus Negri Boschiero, Camila Vantini Capasso Palamim, Manoela Marques Ortega, et al.
Annals of Global Health (2021) Vol. 87, Iss. 1, pp. 44-44
Open Access | Times Cited: 85
Prevalence and characteristics of malaria among COVID-19 individuals: A systematic review, meta-analysis, and analysis of case reports
Polrat Wilairatana, Frederick Ramirez Masangkay, Kwuntida Uthaisar Kotepui, et al.
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 10, pp. e0009766-e0009766
Open Access | Times Cited: 61
Novel α-aminophosphonate derivates synthesis, theoretical calculation, Molecular docking, and in silico prediction of potential inhibition of SARS-CoV-2
Rachida Kerkour, Nadjib Chafai, Ouahiba Moumeni, et al.
Journal of Molecular Structure (2022) Vol. 1272, pp. 134196-134196
Open Access | Times Cited: 45
Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications
Abdullahi Rabiu Abubakar, Ibrahim Sani, Brian Godman, et al.
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 4673-4695
Open Access | Times Cited: 61
COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges
Saikat Dewanjee, Ramesh Kandimalla, Rajkumar Singh Kalra, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3291-3291
Open Access | Times Cited: 54
Misinformation detection using multitask learning with mutual learning for novelty detection and emotion recognition
Rina Kumari, Nischal Ashok, Tirthankar Ghosal, et al.
Information Processing & Management (2021) Vol. 58, Iss. 5, pp. 102631-102631
Closed Access | Times Cited: 53
The role of androgens in COVID-19
Fatemeh Moradi, Behnaz Enjezab, Akram Ghadiri‐Anari
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 6, pp. 2003-2006
Open Access | Times Cited: 52
Natural and Synthetic Drugs as Potential Treatment for Coronavirus Disease 2019 (COVID-2019)
Saba Farooq, Zainab Ngaini
Chemistry Africa (2020) Vol. 4, Iss. 1, pp. 1-13
Open Access | Times Cited: 50
Synthesis, biological evaluation and molecular docking studies of flavonol-3-O-β-D-glycoside as a potential inhibitor of SARS-CoV-2 main protease (3CLpro) in drug development for COVID-19
Gonca Çelik, Şengül Alpay Karaoğlu, Şeyma Suyabatmaz, et al.
International Journal of Biological Macromolecules (2025), pp. 139621-139621
Closed Access
Optimization of photocatalytic parameters for the photodegradation of hydroxychloroquine sulfate using the Ag/Cu-TNT nanocomposite
Emanuel da Cruz Lima, Francisco Xavier Nobre, Gabriel e Silva Sales, et al.
Journal of Water Process Engineering (2025) Vol. 71, pp. 107205-107205
Closed Access
Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment
Bwalya A. Witika, Pedzisai A. Makoni, Larry L Mweetwa, et al.
Molecules (2020) Vol. 25, Iss. 24, pp. 5952-5952
Open Access | Times Cited: 45
Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options
Shetty Ravi Dyavar, Rahul Singh, Rohini Emani, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111794-111794
Open Access | Times Cited: 37
Simple rapid in vitro screening method for SARS-CoV-2 anti-virals that identifies potential cytomorbidity-associated false positives
Kexin Yan, Daniel J. Rawle, Thuy T. Le, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 35
Solar Photocatalysis for the Decontamination Of Water from Emerging Pharmaceutical Pollutant Chloroquine Using Nano ZnO as the Catalyst
Padinchare Veettil Gayathri, Divya Nair, Girish Gopinath, et al.
Water Air & Soil Pollution (2023) Vol. 234, Iss. 3
Open Access | Times Cited: 13
Prevalence of pharmaceuticals and personal care products, microplastics and co-infecting microbes in the post-COVID-19 era and its implications on antimicrobial resistance and potential endocrine disruptive effects
Manish Kumar, Payal Mazumder, Rahul Silori, et al.
The Science of The Total Environment (2023) Vol. 904, pp. 166419-166419
Closed Access | Times Cited: 13
Dexamethasone in COVID-19 treatment: Analyzing monotherapy and combination therapy approaches
Seyed Mohammadmahdi Meybodi, Venus Shahabi Rabori, Darya Salkhorde, et al.
Cytokine (2024) Vol. 184, pp. 156794-156794
Closed Access | Times Cited: 4
COVID‐19: Risk Factors Associated with Infectivity and Severity
Nahla Fadl, Esraa Ali, Tamer Z. Salem
Scandinavian Journal of Immunology (2021) Vol. 93, Iss. 6
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top